Third long-acting injectable antipsychotic using MedinCell’s technology enters preclinical development
9 July 2019
Our news
Bringing you the latest!
Corporate
MedinCell wins the #LetsgoFrance 2019 trophy in the category “France, a model of sustainable economy” (in French)
5 April 2019
MedinCell demonstrates in vivo the efficacy of the first injectable combining surgical anesthesia and 3 days opioid free postoperative pain management
11 March 2019
MedinCell receives 2nd part of the grant from the Bill & Melinda Gates Foundation
24 January 2019
MedinCell receives grant from the Bill & Melinda Gates Foundation
7 December 2017
MedinCell announces investment by CM-CIC Innovation
19 October 2017